Teladoc Health, Inc. (New York Stock Exchange:TDOC)
| Market Cap | $1.58B+16.3% |
| Revenue (ttm) | $2.47B-2.4% |
| Net Income | -$154.82M+30.8% |
| EPS | -$0.86+32.8% |
| Shares Out | 182.29M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,096,814 |
| Open | $8.84 |
| Previous Close | $8.94 |
| Day's Range | $8.64 - $8.94 |
| 52-Week Range | $4.40 - $9.89 |
| Beta | 1.97 |
| Analysts | Hold |
| Price Target | $9.30(+7.02%) |
| Earnings Date | Feb 24, 2027 |
About TDOC
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
8 firms rating TDOC in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 24, 2027Earnings report
$TDOC stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of TDOC by members of U.S. Congress
| Gilbert Ray CisnerosHouse / D | Purchase$15.00K – $50.00K | Nov 19, 2020 |
| Gilbert CisnerosHouse / D | Purchase$15.00K – $50.00K | Nov 19, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$15.00K – $50.00K | Nov 18, 2020 |
| Brad SchneiderHouse / D | Sale$250.00K – $500.00K | Jun 19, 2019 |
| Brad SchneiderHouse / D | Purchase$50.00K – $100.00K | May 7, 2019 |
| Brad SchneiderHouse / D | Purchase$100.00K – $250.00K | May 4, 2018 |
| Brad SchneiderHouse / D | Purchase$15.00K – $50.00K | Jun 4, 2017 |
Recently reported changes in TDOC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by TDOC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
TDOC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
TDOC Revenue by Segment or Geography
| Integrated Care | $398.46M | 56.76% |
| BetterHelp | $206.64M | 29.43% |
| Adjusted EBITDA | $79.36M | 11.30% |
| Stock-based compensation | $11.62M | 1.65% |
| Restructuring costs | $4.40M | 0.63% |
| Acquisition, integration, and transformation costs | $1.56M | 0.22% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New TDOC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to TDOC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in TDOC
| AVUVAvantis U.S. Small Cap Value ETF | $77.28M |
| IWMiShares Russell 2000 ETF | $42.26M |
| VTIVanguard Morningstar Total Stock Market ETF | $33.30M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $31.59M |
| VBVanguard Morningstar Small-Cap ETF | $23.73M |
| DFATDimensional - US Targeted Value ETF | $18.77M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from TDOC’s recent data — informational, not investment advice
What’s Behind the Score
News check: Mixed analyst actions with Oppenheimer and Deutsche Bank raising price targets, but Argus downgraded to Sell; Q3 results show mixed dynamics with insurance growth offsetting cash pay weakness.
Recent Insider Activity
Insider Score Trend Over Time
+0.0 since Sep 4Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| CPAI | Northern Lights Fund Trust III - Counterpoint Quantitative Equity ETF | 2.90% |
| CCON | Direxion Connected Consumer ETF | 2.51% |
| ARVR | First Trust Indxx Metaverse ETF | 1.97% |
| EDOC | Global X Telemedicine & Digital Health ETF | 1.93% |
| PLCY | EventShares U.S. Legislative Opportunities ETF | 1.67% |
| FDHT | FIDELITY DIGITAL HEALTH ETF | 1.44% |
| CTRU | ARK Transparency ETF | 1.18% |
| HEAL | Global X HealthTech ETF | 1.17% |
| NTRL | First Trust Merger Arbitrage ETF | 1.16% |
| BUYO | KraneShares Man Buyout Beta Index ETF | 1.04% |
| MXDU | Nationwide Maximum Diversification U.S. Core Equity ETF | 1.03% |
| PUNK | Subversive Metaverse ETF | 1.03% |
Weight is the stock’s share of each fund’s holdings.